Addition of Cyclophosphamide and Higher Doses of Dexamethasone Do Not Improve Outcomes of Patients With AL Amyloidosis Treated With Bortezomib
Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2017.03.119
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2017
Authors
Publisher
Elsevier BV